-
For a FREE
Consultation -
Current wait:
10 seconds
*By clicking the Submit button, I consent to being contacted by Schuerger Shunnarah Personal Injury Attorneys at the number I provided. I also consent to receiving advertisements and telemarketing messages by text message or pre-recorded call, either of which may be dialed by an autodialer. I acknowledge that my consent is not required for purchase, that standard message and data rates apply, and that clicking Submit constitutes my electronic signature for my consent to being contacted and my agreement to the Terms and Conditions.
The experienced attorneys at Schuerger Shunnarah have helped clients across the country recover over $1 Billion.
Belviq weight loss drugs have been linked to cancer. You need an attorney that has the knowledge and experience in such cases.
Belviq and its extended formula Belviq XR is prescribed for weight-loss in adults with weight-related medical conditions. The drugs are manufactured by Japanese company Eisai Inc. Belviq is known as a selective serotonin 2C receptor agonist, which means it activates very specific parts of your brain that make you feel full. Less hunger leads to less eating, which leads to weight loss.
In February 2020, Belviq was offically recalled by the United States Food and Drug Administration (FDA), after a 5-year study showed convincing links to various forms of cancer. The FDA directed patients to stop taking Belviq and its extended formula variant Belviq XR immediately and dispose of leftover pills. They also issued directives to doctors to discontinue prescribing the treatment to their patients.
Certain forms of cancer were more pronounced in the FDA’s findings:
Unfortunately, these three cancers rank 1st, 2nd and 4th among the deadliest, with an annual death toll totaling more than 250,000 people. The most recent FDA study noted 7.7% of people that were administered Belviq developed some form of cancer.
The Belviq recall makes the manufacturer’s behavior even more egregious considering trials showed tumor growth in rats as far back as 2010, well before its approval in 2012. The manufacturer of Belviq, Eisai Inc., released a statement that they disagreed with the FDA’s findings, though they agreed to a self-recall of the drug as well.
Schuerger Shunnarah has been successful because we poach the best talent from the Big Insurance companies and inspire them to come to the good side.
Once they’re on our team, we capitalize on their insider knowledge to fight the very insurance executives they used to work for.
It’s like taking storm troopers and turning them into Jedi Knights who fight for you.
Contact us now and learn your rights and get advice from an attorney who is on your side and knows how the insurance company game is played.
*By clicking the Submit button, I consent to being contacted by Alexander Shunnarah Personal Injury Attorneys at the number I provided. I also consent to receiving advertisements and telemarketing messages by text message or pre-recorded call, either of which may be dialed by an autodialer. I acknowledge that my consent is not required for purchase, that standard message and data rates apply, and that clicking Submit constitutes my electronic signature for my consent to being contacted and my agreement to the Terms and Conditions.
Learn More Through
Our Social Media
Call mE
Alabama Athens Atlanta Bedford Birmingham Boston Buffalo Dallas Gulfport Georgia Houston Huntsville Little Rock Memphis Milwaukee Mobile Montgomery Nashville New Orleans Panama Pensacola Prattville Selma Tallahassee Indiana Washington DC
Call mE
Alabama Athens Atlanta Bedford Birmingham Boston Buffalo Dallas Gulfport Georgia Houston Huntsville Little Rock Memphis Milwaukee Mobile Montgomery Nashville New Orleans Panama Pensacola Prattville Selma Tallahassee Indiana Washington DC
© Schuerger Shunnarah
Privacy Policy Terms of Service Acceptable Use Policy
Sitemap